The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis
{{output}}
Background: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation and joint destruction. Iguratimod (IGU) is a novel conventional synthetic disease-modifying antirheumatic drugs (csDMARD... ...
